vs
Side-by-side financial comparison of Diversified Energy Co (DEC) and QuidelOrtho Corp (QDEL). Click either name above to swap in a different company.
QuidelOrtho Corp is the larger business by last-quarter revenue ($699.9M vs $666.5M, roughly 1.1× Diversified Energy Co). Diversified Energy Co runs the higher net margin — 29.3% vs -104.7%, a 134.1% gap on every dollar of revenue. Diversified Energy Co produced more free cash flow last quarter ($280.0M vs $-94.7M).
DTE Energy is a Detroit-based diversified energy company involved in the development and management of energy-related businesses and services in the United States and Canada. Its operating units include an electric utility serving 2.2 million customers and a natural gas utility serving 1.3 million customers in Michigan.
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
DEC vs QDEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $666.5M | $699.9M |
| Net Profit | $195.5M | $-733.0M |
| Gross Margin | — | — |
| Operating Margin | 37.6% | -100.7% |
| Net Margin | 29.3% | -104.7% |
| Revenue YoY | — | -3.7% |
| Net Profit YoY | — | -3583.4% |
| EPS (diluted) | — | $-10.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $666.5M | — | ||
| Q3 25 | $499.8M | $699.9M | ||
| Q2 25 | $600.3M | $613.9M | ||
| Q1 25 | — | $692.8M | ||
| Q4 24 | — | $707.8M | ||
| Q3 24 | — | $727.1M | ||
| Q2 24 | — | $637.0M | ||
| Q1 24 | — | $711.0M |
| Q4 25 | $195.5M | — | ||
| Q3 25 | $171.1M | $-733.0M | ||
| Q2 25 | $297.7M | $-255.4M | ||
| Q1 25 | — | $-12.7M | ||
| Q4 24 | — | $-178.4M | ||
| Q3 24 | — | $-19.9M | ||
| Q2 24 | — | $-147.7M | ||
| Q1 24 | — | $-1.7B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 44.7% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 37.6% | — | ||
| Q3 25 | 36.2% | -100.7% | ||
| Q2 25 | 48.5% | -29.4% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | -14.2% | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | -18.4% | ||
| Q1 24 | — | -247.3% |
| Q4 25 | 29.3% | — | ||
| Q3 25 | 34.2% | -104.7% | ||
| Q2 25 | 49.6% | -41.6% | ||
| Q1 25 | — | -1.8% | ||
| Q4 24 | — | -25.2% | ||
| Q3 24 | — | -2.7% | ||
| Q2 24 | — | -23.2% | ||
| Q1 24 | — | -239.9% |
| Q4 25 | — | — | ||
| Q3 25 | $2.14 | $-10.78 | ||
| Q2 25 | $3.67 | $-3.77 | ||
| Q1 25 | — | $-0.19 | ||
| Q4 24 | — | $-2.54 | ||
| Q3 24 | — | $-0.30 | ||
| Q2 24 | — | $-2.20 | ||
| Q1 24 | — | $-25.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $29.7M | $98.1M |
| Total DebtLower is stronger | $2.7B | $2.5B |
| Stockholders' EquityBook value | $984.1M | $2.0B |
| Total Assets | $6.2B | $5.7B |
| Debt / EquityLower = less leverage | 2.76× | 1.23× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.7M | — | ||
| Q3 25 | — | $98.1M | ||
| Q2 25 | $23.7M | $151.7M | ||
| Q1 25 | — | $127.1M | ||
| Q4 24 | — | $98.3M | ||
| Q3 24 | — | $143.7M | ||
| Q2 24 | — | $107.0M | ||
| Q1 24 | — | $78.5M |
| Q4 25 | $2.7B | — | ||
| Q3 25 | — | $2.5B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $2.2B |
| Q4 25 | $984.1M | — | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | $727.7M | $2.8B | ||
| Q1 25 | — | $3.0B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | — | $3.2B | ||
| Q2 24 | — | $3.2B | ||
| Q1 24 | — | $3.3B |
| Q4 25 | $6.2B | — | ||
| Q3 25 | — | $5.7B | ||
| Q2 25 | $5.7B | $6.4B | ||
| Q1 25 | — | $6.5B | ||
| Q4 24 | — | $6.4B | ||
| Q3 24 | — | $6.8B | ||
| Q2 24 | — | $6.7B | ||
| Q1 24 | — | $6.7B |
| Q4 25 | 2.76× | — | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 0.74× | ||
| Q1 25 | — | 0.70× | ||
| Q4 24 | — | 0.72× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.70× | ||
| Q1 24 | — | 0.68× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $464.6M | $-45.5M |
| Free Cash FlowOCF − Capex | $280.0M | $-94.7M |
| FCF MarginFCF / Revenue | 42.0% | -13.5% |
| Capex IntensityCapex / Revenue | 27.7% | 7.0% |
| Cash ConversionOCF / Net Profit | 2.38× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-153.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $464.6M | — | ||
| Q3 25 | — | $-45.5M | ||
| Q2 25 | $264.1M | $-46.8M | ||
| Q1 25 | — | $65.6M | ||
| Q4 24 | — | $63.7M | ||
| Q3 24 | — | $117.9M | ||
| Q2 24 | — | $-97.9M | ||
| Q1 24 | — | $-700.0K |
| Q4 25 | $280.0M | — | ||
| Q3 25 | — | $-94.7M | ||
| Q2 25 | — | $-84.3M | ||
| Q1 25 | — | $9.4M | ||
| Q4 24 | — | $16.5M | ||
| Q3 24 | — | $71.4M | ||
| Q2 24 | — | $-133.2M | ||
| Q1 24 | — | $-66.8M |
| Q4 25 | 42.0% | — | ||
| Q3 25 | — | -13.5% | ||
| Q2 25 | — | -13.7% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 9.8% | ||
| Q2 24 | — | -20.9% | ||
| Q1 24 | — | -9.4% |
| Q4 25 | 27.7% | — | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 8.1% | ||
| Q4 24 | — | 6.7% | ||
| Q3 24 | — | 6.4% | ||
| Q2 24 | — | 5.5% | ||
| Q1 24 | — | 9.3% |
| Q4 25 | 2.38× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.89× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DEC
Segment breakdown not available.
QDEL
| Labs | $373.8M | 53% |
| Point Of Care | $164.6M | 24% |
| Immunohematology | $142.0M | 20% |
| Donor Screening | $14.7M | 2% |
| Molecular Diagnostics | $4.8M | 1% |
| Collaborative Arrangement Transaction With Party To Collaborative Arrangement | $2.1M | 0% |
